20 results
424B5
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Prospectus supplement for primary offering
5:16pm
will be offset in part or at all by potential future cash dividends.
S-8
We are an “emerging growth company,” and the reduced disclosure requirements applicable
20-F/A
2022 FY
TLSA
Tiziana Life Sciences Ltd
13 Jun 23
Annual report (foreign) (amended)
12:37pm
company. Due to a share consolidation, the effect of this was a decrease in share capital of the Company with an offset posted to the merger reserve
F-3
ubxu89 khgshqqi1zl
26 Jan 21
Shelf registration (foreign)
5:31pm
424B5
l2xelo rzwhjti1
10 Apr 20
Prospectus supplement for primary offering
5:22pm
F-1/A
xzuls 15z2ptkrkqo4ji
20 Sep 19
Registration statement (foreign) (amended)
4:51pm
F-1/A
dl6 2ys56ec
17 Sep 19
Registration statement (foreign) (amended)
5:19pm
F-1
fh4 o99hn7a
5 Aug 19
Registration statement (foreign)
4:28pm
DRS
7bnj3bgmeapw
17 Jul 19
Draft registration statement
12:00am
20-F
ik0cd2x lkr
4 Apr 19
Annual report (foreign)
6:07am
424B4
p12221
21 Nov 18
Prospectus supplement with pricing info
6:10am
POS AM
u8snp6n6cmy
14 Nov 18
Prospectus update (post-effective amendment)
12:00am
F-1/A
04u67ovg be
30 Oct 18
Registration statement (foreign) (amended)
12:00am
F-1/A
tumso9xtpxha5k2egn6e
23 Oct 18
Registration statement (foreign) (amended)
1:04pm
F-1/A
oaspaxl
17 Oct 18
Registration statement (foreign) (amended)
8:40pm
F-1
9ie8 s9hyc00rg
26 Jul 18
Registration statement (foreign)
5:06pm
DRS/A
i36rr
10 May 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next